Nov. 09 2011
Source Page: PCT Estate: Future ownership and management of estate in the ownership of Primary Care Trusts in England. 27 p.Found: This will include any contracts for estates and facilities management services and works associated with
Asked by: Yvonne Fovargue (Labour - Makerfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when she last met with Greater Manchester NHS Board to discuss the statutory commissioning of NICE approved medicines.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Ministers have not met with Greater Manchester NHS Board about the statutory commissioning of National Institute for Health and Care Excellence (NICE) recommended medicines. Similarly I am informed that NHS England is not aware of any such discussions.
The National Health Service in England is legally required to make funding available for treatments recommended in NICE technology appraisal and highly specialised technologies guidance, normally within three months of the publication of final guidance. This requirement is reflected in the NHS Constitution as a right to drugs and treatments that have been recommended by NICE for use in the NHS, if their doctor believes they are clinically appropriate.
The NHS Standard Contract is mandated by NHS England for use by commissioners for all contracts for healthcare services other than primary care. The 2024/25 standard contract states that, where any service involves or may involve the prescribing of medicines, the provider must ensure that its formulary reflects all relevant positive NICE technology appraisals. NICE’s guideline on developing and updating local formularies states that when a NICE technology appraisal recommends a medicine, it should be adopted into the local formulary automatically if clinically appropriate and relevant to the services provided by the organisation, and that this process should take place within three months.
Laid - 29 Apr 2024 In Force Not stated
Regulation 2 amends regulation 24 of the National Health Service (Performers Lists) (England) Regulations 2013 (S.I. 2013/335), which provided exemptions to the requirement that a medical practitioner must be a general medical practitioner included in the medical performers list in order to perform primary medical services. It amends the exemption …
Found: Amendment of the National Health Service (General Medical Services Contracts) Regulations 20153.
Asked by: Yvonne Fovargue (Labour - Makerfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what guidance her Department issues NHS trusts on establishing commissioning structures for Health Technology Assessments; and whether trusts have discretion to adopt different processes.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Ministers have not met with Greater Manchester NHS Board about the statutory commissioning of National Institute for Health and Care Excellence (NICE) recommended medicines. Similarly I am informed that NHS England is not aware of any such discussions.
The National Health Service in England is legally required to make funding available for treatments recommended in NICE technology appraisal and highly specialised technologies guidance, normally within three months of the publication of final guidance. This requirement is reflected in the NHS Constitution as a right to drugs and treatments that have been recommended by NICE for use in the NHS, if their doctor believes they are clinically appropriate.
The NHS Standard Contract is mandated by NHS England for use by commissioners for all contracts for healthcare services other than primary care. The 2024/25 standard contract states that, where any service involves or may involve the prescribing of medicines, the provider must ensure that its formulary reflects all relevant positive NICE technology appraisals. NICE’s guideline on developing and updating local formularies states that when a NICE technology appraisal recommends a medicine, it should be adopted into the local formulary automatically if clinically appropriate and relevant to the services provided by the organisation, and that this process should take place within three months.
Mentions:
1: Baroness Morris of Yardley (Lab - Life peer) There is no standard template across the country; every single one of those contracts can take a different - Speech Link
2: Lord Blencathra (Con - Life peer) Different people and organisations negotiate different contracts. - Speech Link
3: Lord Mott (Con - Life peer) We cannot accept the Government always hiding behind confidentiality and contracts as reasons why we - Speech Link
4: Baroness Wheeler (Lab - Life peer) trusts on drawing up and managing procurement contracts. - Speech Link
Correspondence Mar. 27 2024
Committee: Economy and Fair Work CommitteeFound: NHS National Services Scotland - Follow-up from the evidence session Letter from NHS National Services
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the effectiveness of the BALM programme.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
NHS England is currently undertaking a review of how health and wellbeing support could be delivered more effectively. As part of this review, the team will: assess NHS England’s current contracts; work with integrated care boards, National Health Service trusts, and primary care organisations to understand the scale and impact of locally provided provision; and work with system partners and stakeholders including royal colleges, the voluntary sector, and the independent sector to understand how demand for these services has changed over recent years.
Mentions:
1: Baroness Pitkeathley (Lab - Life peer) Service contracts lack incentive for multidisciplinary care and reform is needed to ensure that this - Speech Link
2: Baroness Finlay of Llandaff (XB - Life peer) Many of the bureaucratic blocks could be overcome by honouring contracts that have all staff working - Speech Link
3: Baroness McIntosh of Pickering (Con - Life peer) I ask my noble friend directly: does he agree that neither GPs nor their contracts currently prevent - Speech Link
4: Lord Allan of Hallam (LD - Life peer) It is about writing better contracts and being more insistent with those you are contracting with. - Speech Link
5: Lord Markham (Con - Life peer) and funding, as the noble Baroness, Lady Redfern, also mentioned, the primary care contracts are kept - Speech Link
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many NHS dental contracts have been handed back 7 February 2024.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Monthly data on the Units of Dental Activity (UDA) delivered is published by the NHS Business Services Authority, although this data has an approximate two-month time lag, and therefore we expect data for February 2024 to be published around Mid-May. Otherwise, UDA delivery data is available at the following link:
https://opendata.nhsbsa.net/dataset/english-contractor-monthly-general-dental-activity
Asked by: Navendu Mishra (Labour - Stockport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 April 2024 to Question 21490 on Prosthetics, if her Department will make an assessment of the potential merits of updating the stock of prosthetic limbs available.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The NHS Supply Chain framework for prosthetic componentry will be subject to its next routine procurement exercise in the autumn of 2024, with contracts awarded to commence on 1 April 2025. This does not preclude devices currently not on the framework from being prescribed by prosthetic centres as they are able to order directly from the manufacturer, and report via the exceptions log managed by NHS Supply Chain.